Skip to main content
. 2020 Apr 20;133(8):982–993. doi: 10.1097/CM9.0000000000000682

Figure 3.

Figure 3

Comparison between XOIs and non-XOIs/placebo in MACE with low CV risk (A, P value in Begg test = 0.462, in Egger test = 0.275), in CVE with low CV risk (B, P value in Begg test = 0.851, in Egger test = 0.687). CV: Cardiovascular; CVE: Cardiovascular events; MACE: Major adverse cardiovascular events; XOIs: Xanthine oxidase inhibitors.